| Name | Title | Contact Details |
|---|
Ernest Gallo Clinic and Research Center is a Emeryville, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Health Union integrates the power of human connection with technology to unite people in the shared experiences of life with chronic health conditions. For almost a decade, Health Union has done the hard work every day to bring people living with chronic conditions together. Through a unique and genuine approach to listening and understanding all aspects of health experiences, Health Union`s open, online communities provide a safe place for people to learn, connect and share. In doing so, social interactions evolve into meaningful health conversations. At the same time, these communities offer healthcare companies countless opportunities to understand how to reach and engage people living with these conditions in smarter, more effective ways. Today, the Health Union family of brands includes online health communities for chronic conditions in a range of categories including primary care, immunology, oncology and neurodegenerative/genetic conditions. Among them are Migraine.com, MultipleSclerosis.net, Endometriosis.net and LungCancer.net to name a few. Health Union is dedicated to making an impact on the lives of people with chronic health concerns. In 2018, that focus has been recognized. The company was named among the top 15 percent of the Inc. 5000 list of fastest-growing private companies in America and topped the list of both Philly.com`s “Top Workplaces” and Philadelphia Business Journal`s “Best Places to Work.”
Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.
DxNA is a St George, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Matrixx Initiatives Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Scottsdale, AZ. To find more information about Matrixx Initiatives Inc., please visit www.matrixxinc.com